Logo

American Heart Association

  28
  0


Final ID:

Assessing frailty and its reversal in CV disease (the older age part of the equation)

  • Kitzman, Dalane  ( WAKE FOREST BAPTIST HEALTH , Winston Salem , North Carolina , United States )
  • Pandey, Ambarish  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Author Disclosures:
    Dalane Kitzman: No Answer | Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Sarfez Therapeutics, Edwards Lifesciences, Merck, Bayer, Anumana, Alleviant, Pfizer, Abbott, Axon Therapies, Kilele Health, Acorai, Kardigan, Novartis, Idorsia Pharma, and Science37:Active (exists now) ; Consultant:Rivus:Active (exists now) ; Consultant:iRhythm:Active (exists now) ; Researcher:SQ innovations:Active (exists now) ; Research Funding (PI or named investigator):SC Pharma:Active (exists now) ; Consultant:Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Research Funding (PI or named investigator):Roche:Active (exists now) ; Consultant:Ultromics:Active (exists now) ; Consultant:Roche:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:
You have to be authorized to contact abstract author. Please, Login
Not Available